Biotech Consulting LLC, led by Michael W. Washabaugh, Ph.D., applies over 30 years of experience advancing diverse medical product modalities—including vaccines, therapeutic antibodies, drugs, cellular and gene-based therapies, and viral platforms. Dr. Washabaugh provides strategic guidance to U.S. Government sponsors and private-sector clients on business and product development, encompassing medical products, medical countermeasures, Tech Hubs, and advanced health-related technologies. He has contributed to the global approval of multiple vaccines, biologics, drugs, and biosimilars, bringing deep expertise in regulatory strategy, translational development, and commercialization to accelerate the advancement of innovative medical products addressing critical health needs.
Offering expert guidance in regulatory strategy, business growth, reimbursement planning, and U.S. Government program support for biotech innovation.